Tiratricol 是 T3 和 T4 甲状腺激素的代谢物；促进高脂血症、局部脂肪营养不良和肥胖。它已用于研究 Allan-HERndon-Dudley 综合征治疗的试验。

Tiratricol is a metabolite of T3 and T4 thyroid hormones; promoted for hyperlipidemia, localized lipodystrophy, and obesity. Tiratricol has been used in trials studying the treatment of Allan-Herndon-Dudley Syndrome.

研究表明,Tiratricol可使甲状腺肿减少,对皮质类固醇激素使用降低引起的萎缩也有一定效果。Tiratricol可治疗甲状腺激素抵抗综合征,结合甲状腺素抑制甲状腺癌患者体内促甲状腺激素的产生。

51-24-1

C14H9I3O4

621.935

3,3',5-Triiodothyroacetic acid;替拉曲可

H2O:<1 mgml
Ethanol:93 mg/mL (149.5 mM)
DMSO:93 mg/mL (149.5 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years